Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up
Kimura, H., Kanahara, N., Sasaki, T., Komatsu, N., Ishige, M., Muneoka, K., Ino, H., Yoshimura, K., Yamanaka, H., Suzuki, T., Komatsu, H., Watanabe, H., Shimizu, E., Iyo, M.Volume:
30
Language:
english
Journal:
Journal of Psychopharmacology
DOI:
10.1177/0269881116655978
Date:
August, 2016
File:
PDF, 1.05 MB
english, 2016